Effectiveness and safety of ertugliflozin for type 2 diabetes: a meta ‐analysis data from randomized controlled trials

ConclusionErtugliflozin effectively reduces HbA1c levels and provides extra clinical benefits including body weight and FPG. Common adverse effects including genital mycotic infectious and so on were reviewed.

Source: Journal of Diabetes Investigation - October 5, 2021 Category: Endocrinology Authors: Fudan Zhang, Wenting Wang, Xu Hou Tags: ORIGINAL ARTICLE Source Type: research